Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04227093
PHASE4

Acetazolamide Add-On Therapy to OSA Surgery

Sponsor: University Hospital, Antwerp

View on ClinicalTrials.gov

Summary

Surgical procedures are routinely performed as an alternative to continuous positive airway pressure treatment in patients with obstructive sleep apnea (OSA). However, the response to surgery is often variable. Instability of the respiratory control during sleep (or high loop gain) has been associated with poor surgical results in previous research. Acetazolamide (AZM), a carbonic anhydrase inhibitor, has shown potential in reducing loop gain without affecting other physiological OSA traits. In this protocol the investigators will evaluate the clinical efficacy of AZM add-on therapy to surgical procedures in patients with OSA.

Official title: Acetazolamide as add-on Therapy to Obstructive Sleep Apnea Surgery (ACTOS): a Parallel-group, Double-blind, Placebo-controlled, Randomized Trial

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2020-01-22

Completion Date

2024-08

Last Updated

2024-06-18

Healthy Volunteers

No

Interventions

DRUG

Acetazolamide

Oral acetazolamide tablets of 250 mg taken twice daily.

DRUG

Placebo

Matching placebo tablets taken twice daily.

Locations (1)

Antwerp University Hospital

Edegem, Antwerp, Belgium